ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,194 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryChamPartex.AI Therapeutics AG
Partex.AI Therapeutics AG Logo
Verified· 2 sources

Partex.AI Therapeutics AG

Summary

About the company

The core activity of Cureteq consists of two main areas: 1. **Asset Management**: The company offers services in the field of asset management, which indicates that it is involved in the management and optimization of assets, such as financial investments or company participations. 2. **Biotechnology**: Cureteq is also active in biotechnology, which indicates that it is involved in the development and application of biotechnological processes and products, such as the development of medicines or the application of genetic engineering. Both areas are supported by the application of **artificial intelligence (AI)**, which indicates that the company uses AI technologies to optimize and improve its activities.

AI-generated
Offering

Products & services

LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
Industry:Pharmaceutical Industry
✓ Offered3
AI-assisted drug development
AI-assisted identification of therapeutic indications and clinical development paths for in-licensed, off-strategy drug assets from pharma and biotech; repositioning and de-risking up to the clinically relevant inflection point.
Oncology Asset Incubation
Oncology drug assets in a dedicated oncology vehicle, with focused development, scientific, clinical and strategic support, as well as an SPV structure for targeted further development.
Therapeutic asset development and repositioning
Therapeutic assets are identified, incubated and developed to a clinically relevant inflection point, with the aim of out-licensing back to industry.
Comparisons

Partex.AI Therapeutics AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Partex.AI Therapeutics AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Partex.AI Therapeutics AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Maschinengasse 8
6330 Cham

At a glance

Legal form
Corporation
UID
CHE-469.405.455
Founded
2021 · 5 years
Last commercial register change
April 15, 2026
Employees
11 to 20

Knowledge

No knowledge articles yet

Once Partex.AI Therapeutics AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started

Similar companies

OA
Oncoteq AG
Cham
NT
Nektar Therapeutics Europe GmbH
Zug
EA
Elthera AG
Zug
AP
A2A Pharma AG
Rotkreuz
OG
OrchestratePharma GmbH
Baar
AG
Absci GmbH
Zug
CR
Cancer Research and Biotechnology AG
Baar
OP
Orion Pharma AG
Zug